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1. Introduction 
CAMP and dbcAMP produce opposite metabolic 
effects when added to cultures of mammalian cells 
[l--5]. For example, CAMP increased the glycogen 
content of HeLa cells whereas dbcAMP caused a 
reduction [ 1,3 ] . These differences are due apparently 
to the extracellular catabolism of CAMP and the 
resistance of dbcAMP to degradation. The increase in 
cellular glycogen could be produced by other 
adenosine phosphates and was not due to increase of 
intracellular CAMP concentration [3,6,7]. Extracellular 
catabolism of CAMP pointed to adenosine being the 
active metabolite [2,3,6,8]. Exogenously added CAMP 
or adenosine increases cellular ATP concentration 
[3,9,10], the rate of uridine [2,3,5,8] and thymidine 
[2,3] incorporation into nucleic acids and reduces 
UTP concentrations [2,3,11]. 
The present study demonstrates the catabolism of 
CAMP to adenosine by two serums commonly.used in 
tissue culture. Exogenous CAMP added to lymphoblasts 
in culture, in acting as a precursor of adenosine, 
reduced PP-ribose-P concentrations and thereby 
caused a depletion of pyrimidine nucleotides and 
NAD and inhibited cell growth. The mechanism of 
adenosine-mediated lymphoblast toxicity may be 
relevant to understanding the relationship between the 
immunodeficiency disease associated with human 
adenosine deaminase deficiency [ 121. 
Abbreviations: CAMP, adenosine 3’,5’- cyclic phosphate; 
dbcAMP, N602’-dibutyryl adenosine 3’,5’-cyclic phosphate; 
PP-ribose-P, S-phosphorylribose 1-pyrophosphate; HGPRT, 
hypoxanthine-guanine phosphoribosyltransferase; EHNA, 
erythro-9(2-hydroxy-3-nonyl) adenine. 
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2. Materials and methods 
2.1. Materials 
Radiochemicals were purchased from Amersham 
Searle: [8-14C]adenine, 59 mCi/mmole; [8-‘4C] 
adenosine, 59 mCi/mmole; and [8-3H] CAMP, 
27 Ci/mmole. Adenosine, AMP, CAMP, cGMP, 
PP-ribose-P, and D-ribose-S-phosphate were purchased 
from P & L Biochemicals; dbcAMP from CalBiochem. 
Erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) was 
provided by Dr H. J. Schaeffer, then at Wellcome 
Research Laboratories, North Carolina. 
WI-L2 human lymphoblasts and an HGPRT- 
deficient subline [ 131 were grown in autoclavable 
minimum essential medium with 2 mM glutamine 
and 10% horse serum (Flow Laboratories) and 
maintained between lo4 and lo6 cells per ml. Cell 
counts were measured using a Coulter counter, 
model Zn, . 
2.2. Measurement of cellular nucleotide and erotic 
acid concentrations 
Acid-soluble nucleotides were separated on a 
Varian LCS-1000 high-pressure liquid chromatograph 
equipped with a 3-meter capillary column packed with 
Varian PA-38 anion exchange resin; the nucleotide 
elution profile was essentially as previously described 
[ 14,151. Peak areas were determined by height 
multiplied by width at half height and compared to a 
series of known standards. AMP and IMP have 
coincident retention times and their area has been 
arbitrarily ascribed solely to AMP. Orotic acid also 
has a retention time nearly coincident with AMP and 
was therefore quantitated by subjecting samples to 
hydrolysis in 1 N HCl at 100°C for 60 min or con- 
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verting the erotic acid to OMP by incubation of 
neutralized extracts with partially purified yeast 
orotate phosphoribosyltransferase (Sigma) and 
PP-ribose-P prior to nucleotide analysis. Cells were 
harvested and extracted for analysis as previously 
described [ 151. 
2.3. Assay of cAMPand adenosine metabolism 
After incubation of [3H] CAMP or [ 14C] adenosine 
in medium containing 10% horse or fetal calf serum 
for various times, 0.050 ml aliquots were added to 
tubes containing 0.010 ml 8 M formic acid, and 
0.025 ml were spotted on cellulose thin layers 
(Eastman Kodak) for separation of CAMP, AMP, and 
adenosine in isopropyl alcohol-concentrated 
ammonia-water (7: 1: 2) [ 161; or nucleotides, 
inosine, hypoxanthine, adenosine, adenine, in 
n-butanol-methanol-water-ammonia (60:20:20: 1) 
[ 171. Separated compounds were cut out and 
counted [ 171. 
2.4. Assay of intracellular PP-ribose-P concentration 
and PP-n’bose-P synthetase activity 
PP-ribose-P concentrations were measured by a 
modification of a previously reported method [8] . 
PP-ribose-P synthetase (EC 2.7.6.1) activity was 
measured on the day of harvesting in parent and 
HGPRT deficient lymphoblast lysates after centrifuga- 
tion, 20 OOOg, and passage of supernatant through 
Sephadex GlO. Order of substrate additions were 
important in this assay (R. C. Willis, personal com- 
munication) as modified from a previous method [ 191; 
assays were started by simultaneous addition of 5 mM 
ATP and 65 PM [‘“Cl adenine, after 10 min preincuba- 
tion of enzyme and 1 mM ribose-5-phosphate. 
3. Results 
3.1. Catabolism of CAMP in horse and fetal calf serum 
CAMP is converted to adenosine in medium con- 
taining 10% horse serum; the rate limiting step is 
conversion of CAMP to AMP (fig.1). The rates of 
CAMP catabolism (40 PM) in 10% horse and calf 
serum were 5.1 and 1.3 pmol/h, respectively. In 
medium containing 10% horse serum, the product 
adenosine accumulates because less than 5% of 
50 E.~M adenosine is metabolized in 30 h at 37°C; 
this medium was used in all studies. Lymphoblast 
growth is inhibited more by CAMP than adenosine 
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Fig.1. Metabolism of [ 3H]~AMP in medium containing 10% 
horse serum at 37°C. CAMP(O), AMP (A), adenosine (n). 
at 50 PM, because the adenosine slowly generated 
from CAMP is not as effectively deaminated by 
cellular adenosine deaminase, having a KM of approx. 
30 I.~M [20,2 l] , as a single addition of adenosine. 
3.2. Effect of cAMPon lymphoblast nucleotide and 
oro tic acid concentrations 
50 I.~M dbcAMP had little effect on growth rate 
whereas 50 PM CAMP produced transient growth 
inhibition (2-3 days, fig.2) and 500 PM CAMP 
arrested growth and ultimately caused cell death. 
0 24 40 72 96 120 
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Fig.2. Inhibition of WI-L2 lymphoblast growth by CAMP 
and reversal by uridine. Lymphoblasts were cultured in 
medium containing 10% horse serum with no additions (0); 
50 PM CAMP (0); 50 r.rM CAMP with 100 PM uridine added 
at 0 h (A), or 24 h (v). 
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Table 1 
Effect of 10 h incubation with 500 PM CAMP upon 
nucleotide pools of human lymphoblasts 
Nucleotide 
AMP 
ADP 
ATP 
Total AXP 
NAD 
GMP 
GDP 
GTP 
Total GXP 
UDP 
UTP 
CTP 
UDP-sugars 
Orotate 
Control CAMP 
(nmoles/106 cells) Ratio 
n=8 n=5 cAMP:control 
0.25 r 0.08 0.13* f 0.03 
0.46 * 0.13 0.66 f 0.31 
4.79 t 0.48 7.75 f 3.11 
5.50 a.54 1.55 
0.93 r 0.06 0.48 f 0.22 0.52 
oJJ7 f 0.04 - 
0.15 f 0.05 0.18 f 0.08 
1.21 * 0.41 1.38 f 0.63 
1.43 1.56 1.09 
0.25 f 0.12 0.05 * 0.03 
1.96 f 0.16 0.10 * 0.04 0.05 
0.79 f 0.11 0.13 f 0.04 0.17 
1.23 f 0.19 0.43 f 0.27 0.35 
<o.o2a 1.34a ?r 0.14 
Adenylate 
energy charge 0.91 0.95 
Lymphoblasts in mid-log phase growth (2-5 X 10’ cells/ml), were 
incubated in the presence or absence of 500 MM CAMP for 10 h 
at 37°C and the nucleotide concentrations determined by high 
pressure liquid chromatography. Results are the mean ? 1 S.D. of n 
experiments. The adenylate energy charge = (ATP + 0.5 ADP)/ 
(ATP + ADP + AMP). 
an=3 
After a 1 O-h incubation of lymphoblasts with 500 /.IM 
CAMP, the NAD, UDP-sugars, and particularly UTP 
and CTP concentrations were greatly reduced; the 
concentration of ATP increased (table 1). There was no 
change or slight increase in the adenylate nergy 
charge [22]. The CAMP, 500 PM, dependent decrease 
in UTP and CTP and increase in ATP were detectable 
at times as early as 2 or 4 h with maximal changes 
between 6 and 10 h. 
During 10 h incubation with a range of CAMP con- 
centrations (fig.3), as little as 10 PM CAMP decreased 
Fig.3. Effect of 10 h incubation with a range of CAMP con- 
centrations on lymphoblast nucleotide concentrations. Percent 
of the control nucleotide concentrations given in table 1 for 
ATP (o - .), GTP (A - A), NAD (m - l ), UTP (o --o), 
CTP (4 - -a), UDP-sugars (0 - - 0). 
= 
1 
0 
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pyrimidine nucleotide and GTP concentrations. The 
decrease in pyrimidine nucleotides and GTP were not 
related exclusively to an increase in ATP concentration. 
GTP returned to control or increased concentrations 
only at CAMP concentrations which resulted in 
increased ATP concentrations (fig.3). 
The incubation of lymphoblasts with CAMP not only 
caused a gross depletion of pyrimidine nucleotides, 
but an accumulation of erotic acid (table 1). Addition 
of orqtic acid, 500 PM, to lymphoblast cultures did 
not inhibit growth. Uridine, 100 PM, prevented or 
partially overcame the CAMP growth inhibition 
(fig.2) similar findings have been reported [ 111. 
3.3. Intracellular PP-ribose-P concentrations 
The depletion of NAD and pyrimidine nucleotides 
and particularly the accumulation of erotic acid, 
which requires PP-ribose-P for further metabolism, 
suggested the synthesis of PP-ribose-P may be inhibited. 
After 6 h exposure to 50 PM CAMP, AMP, or adenosine, 
intracellular PP-ribose-P concentrations were reduced 
by more than 80% (table 2). The greatest sustained 
depletion of PP-ribose-P at 24 h was produced by the 
combination of adenosine, 50 PM, and EHNA, 5 PM, 
an adenosine deaminase inhibitor [23] which 
inhibited lymphoblast adenosine deaminase activity 
by greater than 95%. 
3.4. Effect of cAMPand adenosine on PP-ribose-P 
synthetase activity 
The adenosine effect of reducing PP-ribose-P 
concentrations was apparently not mediated through 
inhibition of PP-ribose-P synthetase activity. The 
following compounds produced less than 10% change 
of PP-ribose-P synthetase activity in parent and 
HGPRT-deficient lymphoblast lysates: 500 PM 
adenosine, 5 /.IM EHNA, adenosine and EHNA in 
combination. The nucleotides, 100 PM CAMP or 
cGMP, also produced less than 5% change in PP- 
ribose-P synthetase activity at either 10e3 or lOA M 
ATP. PP-ribose-P synthetase activity was 2.9 nmol/mg 
protein per min. 
4. Discussion 
These results demonstrate the conversion of CAMP 
to adenosine in culture medium supplemented with 
either fetal calf or horse serum (fig. 1). Addition of 
CAMP to human lymphoblasts in culture provided a 
precursor for the slow generation of adenosine, 
which resulted in a depletion of pyrimidine nucleotides 
and NAD and an accumulation of erotic acid (table 1) 
The depleted pyrimidine nucleotide pools account for 
the increased rates of labelled uridine [2,3,5,8] and 
thymidine [2,3] incorporation into nucleic acids of 
CAMP-adenosine treated cells. 
Table 2 
Effect of adenosine phosphates and adenosine on lymphoblast 
PP-ribose-P concentration 
Intracellular PP-ribose-P 
(nmoles/109 cells) 
Additions 6h Relative 24 h Relative 
concentration concentration 
None 175 1.00 244 1.00 
Adenosine, 50 PM 28 0.16 47 0.19 
AMP, 50 /.IM 16 0.09 33 0.14 
CAMP, 50 PM 24 0.14 40 0.17 
EHNA, 5 /.JM 155 0.89 199 0.81 
EHNA, 5 /.IM + 39 0.22 16 0.07 
adenosine, 50pM 
Lymphoblasts in log phase growth were incubated with compounds for 6 
or 24 h after which cells were extracted and PP-ribose-P concentrations 
were determined. 
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The reduction in cellular nucleotides and accumula- 
tion of erotic acid appear to be a consequence of
reduced PP-ribose-P concentration (table 2). An 
inhibition of nucleotide and PP-ribose-P synthesis 
was not mediated by an imbalance in the adenylate 
energy charge (table 1). The low ATP:ADP ratio in a 
previous report, 1.7 for control, and 1.4 for adenosine 
treated cells [ 1 l] may reflect degradation during 
extraction or dead cells. An ATP:ADP ratio of 10 for 
adenosine treated cells, similar to the present results 
has also been reported [9]. Adenosine or CAMP also 
did not inhibit PP-ribose-P synthetase activity in 
lymphoblast lysates. Early addition of uridine over- 
came the CAMP-adenosine mediated growth inhibition 
(fIg.2) and phosphorylation of uridine and adenosine 
could provide pyrimidine and purine nucleotides 
independent of PP-ribose-P. At varied CAMP con- 
centrations GTP returned to normal or increased 
concentrations only as ATP became greater than 
control concentrations (fIg.3) suggesting guanine 
nucleotides were derived from the expanding adenine 
nucleotide pool formed from adenosine. 
Adenosine causes an increase in the glycogen 
content of cultured human cells [ 1,3] and has now 
been shown to decrease PP-ribose-P concentrations of
human lymphoblasts. The purine analogs, 9-hydroxy- 
alkyl- and 9-aminoalkyl purines, have been shown to 
inhibit the rate of PP-ribose-P dependent reactions 
and reduce the PP-ribose-P concentrations in tumor 
cells [24]. An adenosine analog which cannot be 
phosphorylated to the 5’-nucleotide, 2’S’-dideoxy- 
adenosine, also decreased the concentration of 
PP-ribose-P in mouse lymphoma cells [25] . The 
site(s) of action of these compounds and adenosine 
remain to be elucidated. The adenosine mediated 
increase in glycogen and decrease in PP-ribose-P 
concentrations suggest adenosine may cause an 
increase in glycogenesis and decrease in pentose 
phosphate synthesis. 
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